Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Tough Times for Pharma A Boon for Skin Care? - Happi
Company News

Tough Times for Pharma A Boon for Skin Care?

Is a shift from blockbuster drugs to dermatologicals ahead?

Changes in the pharmaceutical industry may be driving companies to prescription pharmaceutical drugs where demand is stronger, according to a report from market research firm Kalorama Information. 
 
“Reliance on blockbuster drugs is all but over, causing a shift of focus for many drug research and development entities,” said Bruce Carlson, publisher of Kalorama Information.  “By focusing on cosmetic medications, many manufacturers are realizing less scrutiny from the FDA and a growing need in the niche markets such as dermatology.”
 
Kalorama thinks this transition will play a role in the future development of the dermatological industry over the next five years, as  pharma companies need to get creative in an environment of financial difficulty and patent losses. 
 
The pharmaceutical industry is facing a tougher environment in general, due to harder regulations for gaining approvals for mainstream products, economic issues, and a dwindling pipeline of new products.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters